Candriam Equities L Biotech.C EUR/ LU1120766388 /
NAV24/05/2024 | Var.-0.2500 | Type of yield | Focus sugli investimenti | Società d'investimento |
---|---|---|---|---|
216.4600EUR | -0.12% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensile
gen | feb | mar | apr | mag | giu | lug | ago | set | ott | nov | dic | Totale | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2015 | - | - | - | - | - | -0.99 | 5.05 | -12.19 | -11.06 | 8.94 | 8.18 | -2.47 | - |
2016 | -22.94 | -4.98 | -1.15 | 3.16 | 8.63 | -8.23 | 11.81 | -2.00 | 3.03 | -10.54 | 12.73 | -2.27 | -17.18% |
2017 | 2.97 | 8.66 | -0.57 | -0.74 | -6.02 | 7.82 | -0.95 | 5.93 | 1.46 | -5.24 | -2.17 | 0.73 | +11.22% |
2018 | 2.84 | -2.57 | -2.96 | -1.49 | 8.26 | 0.77 | 4.17 | 4.70 | -1.93 | -11.86 | 4.19 | -9.20 | -6.81% |
2019 | 12.70 | 4.36 | 0.82 | -4.77 | -3.93 | 7.06 | 0.91 | - | - | - | - | - | - |
2021 | - | - | - | - | - | - | 31.91 | 4.35 | -2.47 | 0.30 | -1.70 | 1.34 | - |
2022 | -9.30 | -1.76 | 7.03 | -2.16 | -5.45 | 6.05 | 7.35 | 2.94 | 0.68 | 5.55 | 1.91 | -6.30 | +4.91% |
2023 | 1.12 | -3.40 | -2.17 | 0.63 | 2.56 | -0.90 | -1.63 | 1.34 | -2.10 | -5.97 | 2.83 | 12.21 | +3.49% |
2024 | 3.19 | 1.72 | 0.15 | -5.32 | 2.53 | - | - | - | - | - | - | - | - |
Calculated values
YTD | 6 mesi | 1 anno | 3 anni | 5 anni | |
---|---|---|---|---|---|
Volatilità | 15.97% | 17.06% | 15.97% | 21.45% | 21.38% |
Indice di Sharpe | 0.10 | 1.95 | 0.14 | - | 0.25 |
Mese migliore | +12.21% | +12.21% | +12.21% | +12.21% | +31.91% |
Mese peggiore | -5.32% | -5.32% | -5.97% | -9.30% | -9.30% |
Perdita massima | -9.57% | -9.57% | -14.01% | -19.84% | -19.84% |
Outperformance | -3.05% | - | -1.13% | +0.44% | - |
Tutte le quotazioni in EUR
Tranches
Nome | Type of yield | Prezzo di riacquisto | 1 anno | 3 anni | |
---|---|---|---|---|---|
Candriam Equities L Biotechnolog... | reinvestment | 2,030.7400 | +7.80% | +10.19% | |
Candriam Equities L Biotech.C EU... | reinvestment | 216.4600 | +6.00% | - | |
Candriam Equities L Biotech.I-H ... | reinvestment | 2,034.2400 | +5.49% | +2.50% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,184.0500 | +6.90% | +24.03% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,346.1101 | +4.58% | +20.63% | |
Candriam Equities L Biotech.R GB... | reinvestment | 350.9100 | +4.66% | +24.39% | |
Candriam Equities L Biotech.R EU... | reinvestment | 319.4000 | +6.99% | +26.57% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 197.9600 | +3.03% | +0.77% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 1,816.7100 | +8.10% | +12.95% | |
Candriam Equities L Biotech.N-H ... | reinvestment | 147.1500 | - | - | |
Candriam Equities L Biotech.N US... | reinvestment | 590.6100 | +6.49% | +8.01% | |
Candriam Equities L Biotech.I US... | reinvestment | 5,556.5698 | +7.69% | +9.81% | |
Candriam Equities L Biotech.C-H ... | reinvestment | 194.4000 | +4.66% | +2.02% | |
Candriam Equities L Biotech.R-H ... | reinvestment | 202.7200 | +5.56% | +4.53% | |
Candriam Equities L Biotech.R US... | reinvestment | 263.3200 | +7.83% | +12.11% | |
Candriam Equities L Biotechnolo... | reinvestment | 829.0700 | +6.88% | +9.38% | |
Candriam Equities L Biotechnolog... | paying dividend | 757.1800 | +6.85% | +9.27% |
Prestazione
YTD | +2.05% | ||
---|---|---|---|
6 mesi | +16.93% | ||
1 anno | +6.00% | ||
3 anni | - | ||
5 anni | +54.54% | ||
10 anni | - | ||
Dall'inizio | +44.31% | ||
Anno | |||
2023 | +3.49% | ||
2022 | +4.91% | ||
2018 | -6.81% | ||
2017 | +11.22% | ||
2016 | -17.18% |